Georgia Health Initiative: September 2025
A new report, “Progress Towards Vitality: A 10-Year Retrospective Analysis of Systems Focused Efforts to Improve Maternal Health in Georgia,” analyzes a subset of recommendations put forward by the Georgia Maternal Mortality Review Committee (MMRC) and the Georgia House Study Committee on Maternal Mortality to improve maternal mental health in the state.
Philanthropy @ Work – Grants and Programs – May 2025
The latest on grants and programs from the field.
Act Now to Protect Philanthropy, Medicaid, and SNAP
Right now, Congress is finalizing a massive budget reconciliation bill that threatens philanthropy’s freedom to give and endangers the health and well-being of many millions of Americans. We are reaching out today to raise awareness of three critical developments in the ongoing budget reconciliation process and to encourage you to act.
Health and Well-Being Threatened in The First 100 Days
Statement from GIH President and CEO Cara V. James on First 100 Days
Power to the People: Advancing Impact Through Participatory Budgeting
Who is best positioned to determine how health funding should be allocated? At the Community Health Commission of Missouri (CHCM), we believe the answer is clear: the people most affected by health disparities.
Philanthropy, Stewarding a Just America
In a time of intensive action to dismantle policies and practices that protect the well-being of all Americans, where chaos is the principal strategy to overthrow the will of and care for the American people, philanthropy must remain rooted in what is legally and morally right.
How Pew Is Learning to Improve Health Policy
Antibiotics revolutionized medical treatment and are a cornerstone of modern health care. However, the global rise of antibiotic-resistant bacteria is making infections costlier and deadlier. After a 2008 report commissioned by The Pew Charitable Trusts highlighted these concerns, the organization invested in multiple projects to set limits on the use of antibiotics and to spur the development of new drugs.